definiens: shall mean any rights or protections which are recognized, afforded or granted by the FDA or any other Regulatory Authority in any country or region of the Territory, inassociation with the Marketing Authorization of the Product, providing the Product : ( a ) a period of marketingexclusivity, during which a Regulatory Authority recognizing, affording or granting such marketing exclusivity shallrefrain from either reviewing or approving a marketing authorization application or similar regulatory submission, submitted by a Third Party seeking to market a Competitive Product, or ( b ) a period of data exclusivity, during which aThird Party seeking to market a Competitive Product is precluded from either referencing or relying upon, without anexpress right of reference from the dossier holder, the Product ’s clinical dossier or relying on previous RegulatoryAuthority findings of safety or effectiveness with respect to such Product to support the submission, review orapproval of a marketing authorization application or similar regulatory submission before the applicable RegulatoryAuthority